RAPILYSIN 10 IU _ Infusion
Reteplase (Recombinant plasminogen sctivator)
10 IU
CENEX
| Pack size | 2 Vials (Dry) + 2 Solvent Syringe (10ml) + 2 Spikes + 2 Needles |
|---|---|
| Dispensing mode | POM |
| Source | FRANCE |
| Agent | DUPHARM |
| Retail Price | 6087.50 AED |
Indications
RAPILYSIN 10 IU _ Infusion is used for:
For lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Reteplase (Recombinant plasminogen sctivator) :
Mechanism of Action
Reteplase binds to fibrin rich clots via the fibronectin finger-like domain and the Kringle 2 domain. The protease domain then cleaves the Arg/Val bond in plasminogen to form plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action.
Note
RAPILYSIN 10 IU _ 10 IU Infusion manufactured by CENEX. Its generic name is Reteplase (Recombinant plasminogen sctivator). RAPILYSIN 10 IU _ is availble in United Arab Emirates.
Farmaco UAE drug index information on RAPILYSIN 10 IU _ Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.